The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The Centers for Medicare and Medicaid Services has confirmed the standard monthly premium will rise to $202.90 next year.

In mid-June, the Medicare Trustees Report had estimated the Part B premium would rise by a scorching-hot 11.5% to $206.20 per ...

The reduced prices were negotiated through the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion ...

The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its ...

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.